ramucirumab - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
CYRAMZA ramucirumab 100 mg/10 mL solution for intravenous infusion vial AUST R: 227351Active ingredients:
ramucirumab
Dosage form:
Injection, intravenous infusion
Sponsor:
Eli Lilly Australia Pty Ltd
Phone:
1800454559
|
Deletion from market:
30 Jun 2025
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Patients are advised to consult their healthcare professional to discuss alternative treatment options.
|